WebApr 13, 2024 · This study was conducted to identify ischemic heart disease-related factors and vulnerable groups in Korean middle-aged and older women using data from the Korea National Health and Nutrition Examination Survey (KNHANES). Among the 24,229 people who participated in the 2024–2024 survey, 7249 middle-aged women aged 40 and over … WebFeb 23, 2010 · Helsinski Heart Study - Helsinki Heart Study. May 03, 2004 . Share via: Print; Font Size A A A. Date Presented: 01/01/1987 Date Published: 01/01/1987 Date …
Abstract - OUP Academic
Web2 days ago · Kalevi Pyörälä (1930–2024). He graduated as physician in 1954 and became specialist in internal medicine in 1961 and in cardiology in 1965. During 1969–75 he served as assistant professor of internal medicine at the University of Helsinki and from 1975–93 as professor of medicine at the University of Kuopio and senior physician at the ... WebThe Helsinki Heart Study (HHS) is a randomized double-blinded trial that assessed the primary cardiovascular preventive effect of elevation in HDL and decrease in non-HDL cholesterol with gemfibrozil . Study Description Publications bjr hackathon
The Helsinki Heart Study: basic design and randomization …
WebI work as a coordinator of an international multicenter observational study named Epitranscriptomics of ischemic heart disease, IHD-EPITRAN, at the University of Helsinki, Faculty of Medicine, Department of Pharmacology as a PhD student. With special focus on ischemic heart disease, my principal scientific interests center on deepening and … WebJul 1, 1992 · Of the 4081 men participating in the Helsinki Heart Study, a coronary primary prevention trial with gemfibrozil in middle-aged men with high non-high-density lipoprotein (HDL) cholesterol (> 5.2 mM; 200 mg/dL), 135 had NIDDM at entry. The incidence of definite myocardial infarction and cardiac death and changes in serum and lipoprotein lipids ... WebMar 17, 2024 · The primary end point occurred in 1344 patients (9.8%) in the evolocumab group and in 1563 patients (11.3%) in the placebo group (hazard ratio, 0.85; 95% CI, … bj resturant brewery nanuet